As of my last update in October 2023, TBAJ-5307, identified by the CAS number 2332831-92-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and detailed biological activity may not be widely documented in public databases, compounds like TBAJ-5307 are typically evaluated for their solubility, stability, and reactivity. In research contexts, such substances are often studied for their interactions with biological targets, which may include enzymes or receptors, and their efficacy in treating specific conditions. Safety profiles, including toxicity and environmental impact, are also critical aspects of their characterization. For precise information, including experimental data and applications, consulting specialized scientific literature or databases is recommended, as ongoing research may provide new insights into the properties and uses of TBAJ-5307.

TBAJ-5307

2332831-92-0: As of my last update in October 2023, TBAJ-5307, identified by the CAS number 2332831-92-0, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. While specific characteristics such as its molecular structure, physical properties, and detailed biological activity may not be widely documented in public databases, compounds like TBAJ-5307 are typically evaluated for their solubility, stability, and reactivity. In research contexts, such substances are often studied for their interactions with biological targets, which may include enzymes or receptors, and their efficacy in treating specific conditions. Safety profiles, including toxicity and environmental impact, are also critical aspects of their characterization. For precise information, including experimental data and applications, consulting specialized scientific literature or databases is recommended, as ongoing research may provide new insights into the properties and uses of TBAJ-5307.

<p>TBAJ-5307 is a broad-spectrum anti-non-tuberculous mycobacteria inhibitor that targets the FO-domain of the engine, preventing rotation and proton-translocation. TBAJ-5307 inhibits non-tuberculous mycobacteria in vitro and in vivo [1].</p>

CAS 2332831-92-0

TBAJ-5307

TBAJ-5307

Ref: TM-T87495